Drug recall · July 22, 2026
Nystatin Cream USP recall
Why: Subpotent Drug: Low out of specification assay results performed during long-term stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Nystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, Israel, NDC 45802-059-35
- Lots / codes
Lot #: 205060, Exp 09/30/2027
- Quantity
- 180,936 tubes
- Company
- Padagis US LLC, Minneapolis, MN
- Distribution
- USA Nationwide
- Initiated
- June 23, 2026 · Voluntary: Firm initiated
- Classified
- July 13, 2026
- Reported
- July 22, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nystatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.